Ann: Sensera completes A$2.5m private placement, page-158

I don't think Ralph took his bat & ball and left us in the lurch, " best of luck and god willing ".

I prefer to think of Sensera as having been in a period of hibernation, or a self-induced coma.

Back in mid-2020 things were dire, very dire indeed.
Covid19, economic and political uncertainty & malaise the macro backdrop to a series of bad news events for Sensera.
The cornerstone customer, AbioMed, had run into technical issues and hospitals were overrun with covid patients. Forward orders dropped by 70%.
Nova Biomedical's CGM launch was delayed, from late 2020 to 2nd half 2021 at best.
NanoDX promised much, but the chance of commercialisation was 50/50 ... and was left out of conservative planning revenue calculations for the next 12 months.
New work and customer enquiries had virtually stopped as prospective customers pulled new product development due to Covid and an uncertain future.

The only strategy available to Ralph and the board at this time would be sell all non-essential assets, pay off all debt, reduce variable costs to the bare bones, and have the company running on the smell of an oily rag (a self induced coma) until such time as our key customer fortunes changed. This just left Tim, an experienced COO at the helm, and Ralph offering support from the sidelines. And during this time all but the minimum communication to shareholders ( the SP would have been less than .01c if this had been communicated this clearly ).

In this state of coma the company must remain until the first signs of spring indicate it's time to stir.
It's as if the last 12 - 18 months never happened.

What would be the indicators that spring is upon us, and it's time to come out of the coma.

AbioMed - returning to pre-Covid demand, having sorted out there technical issues, and hospital surgeries returning to normal scheduling.
Nova BioMedical - volume commercial orders, indicating the launch of the the Sanvita OneView CGM is imminent
NanoDX - actually submitting for EUA and preparing for launch.
New Customers - several new customers and leads generating initial development work

All on the backdrop of a healthy macro environment. Political stability, pandemic under control and a healthy economy.

And this is where I believe we are, coming out of hibernation. The CR was a surprise to me, but I hope it was both a final " shot in the arm" to ensure we safely come out of hibernation ( and don't slip back ! ), and directly to meet a need for resource to facilitate a growing order book.

The added bonus, which we couldn't have foreshadowed, was the Biden Presidency and the decision to actively subsidise the semi-conductor industry. This may well provide much needed tail winds and some much needed good fortune for Sensera.

It will be interesting to see how the company rebuilds as these customers come on line, we turn cash positive, and we can actually invest to build a dynamic business in a dynamic industry which promises such a prosperous future.

And at the end of all of this, the turnaround king may well have played his best hand yet.

All IMO
GLTAH